Editorial Board

Dr Wil Ngwa is founding Director of the Global Health Catalyst launched at the Harvard Radcliffe Institute in 2015, and dedicated to catalyzing high impact collaborations to reduce global cancer health disparities, especially involving USA and low and middle income country institutions (LMIC).  He is also a distinguished full professor of public health at ICTU.   

Dr Ngwa has held professorships at the University of Massachusetts and Tufts University, and guest professorships at the University of Pennsylvania, USA, and University of Heidelberg, Germany.  He is a founder of the Global Oncology University, with an award-winning win-win collaborative education model that offers everyone access to the same world class education and training available from professors at the world’s best institutions.

Dr Ngwa is widely recognized for his strong commitment as as a leader to enhance diversity and inclusion involving minorities in the USA, and building high impact collaborations between USA and LMIC to eliminate global oncology disparities, working with individuals, institutions, the diaspora, industry and government to ensure sustainability and impact.  Dr Ngwa has won numerous awards including over 20 prestigious awards/honors over the past 6 years alone from Harvard, the United States National Institutes of Health, the American Association of Physicists in Medicine, and international professional societies and organizations for his leading efforts in global  health and radiation oncology.

He has published 4 Books and over a hundred articles including in high impact Journals like Nature, Science, the Lancet and the Red Journal.  He has been a chair of the Lancet Oncology Commission for Sub-Saharan, Editor of the IOP Publishing series on global oncology, with service on the editorial boards of other journals focused on oncology. His research interests are in developing low-cost approaches and technologies for increasing access to cancer care, research and education especially in radiation oncology, with focus on addressing cancer health disparities in the USA and in global health.